You are here

National Institutes of Health (NIH)

For the millions of people living with a rare disease, the novel coronavirus disease COVID-19 presents unique challenges.

The trial is now enrolling hospitalized adults with COVID-19 in the United States.

More than one effective vaccine approach likely will be required to successfully protect the global community from SARS-CoV-2.

Treatment with disulfiram, normally prescribed to treat alcohol use disorder, shows health benefits in animal study.

Study enrolling adults with mild to moderate COVID-19 in the United States.

NIH-funded study is first population-wide estimate of autism risk of children whose aunts or uncles have the condition.

ever has a public-private biomedical research effort of this scope and scale come together with such speed and determination.

Researchers to evaluate medical records of 21,000 pregnant women

Preliminary results from NIH clinical trial published.

Pages